Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress

Neuroscience Bulletin

Volumn 26, Issue 1, 2010, Pages 17-27

  Kumar, Anil ^a   Kumari, Beenta ^a   Kumar, Puneet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chronic fatigue syndrome; Meloxicam; Naproxen; Nimesulide; Rofecoxib; Valdecoxib

Indexed keywords

CATALASE; GLUTATHIONE; MALONALDEHYDE; MELOXICAM; NAPROXEN; NIMESULIDE; NITRITE; ROFECOXIB; VALDECOXIB;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; ARTICLE; BRAIN LEVEL; CHRONIC DRUG ADMINISTRATION; CHRONIC FATIGUE SYNDROME; CHRONIC STRESS; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; FORCED SWIMMING TEST; LIPID PEROXIDATION; LOCOMOTION; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; CATALASE; CHRONIC DISEASE; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; GLUTATHIONE; ISOXAZOLES; LACTONES; LIPID PEROXIDATION; MALE; MEMORY; MICE; MOTOR ACTIVITY; NAPROXEN; NITRITES; RANDOM ALLOCATION; STRESS, PSYCHOLOGICAL; SULFONAMIDES; SULFONES; THIAZINES; THIAZOLES;

EID: 76649098313     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-0713-x     Document Type: Article

References (64)

1. C.D. Munhoz B. Garcia-Buenoz J.L.M. Madrigal L.B. Lepsch C. Scavone J.C. Leza 2008 Stress-induced neuroinflammation: mechanisms and new pharmacological targets Braz J Med Biol Res 41 1037 1046 10.1590/S0100-879X2008001200001 1:CAS:528:DC%2BD1MXjsV2nurc%3D 19148364
2. D. Chambers A.M. Bagnall S. Hempel C. Forbes 2006 Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review J R Soc Med 99 506 520 10.1258/jrsm.99.10.506 17021301 (Pubitemid 44690264)
3. L.A. Jason K. Corradi S. Gress S. Williams S. Torres-Harding 2006 Causes of death among patients with chronic fatigue syndrome Health Care Women Int 27 615 626 10.1080/07399330600803766 16844674 (Pubitemid 44091810)
4. P. Sanders J. Korf 2007 Neuroaetiology of chronic fatigue syndrome: an overview World J Biol Psychiatry 8 1 7
5. B.S. McEven R.M. Sapolsky 1995 Stress and cognitive function Curr Opin Neurobiol 5 205 216 10.1016/0959-4388(95)80028-X
6. R.D. Porsolt A. Bertin M. Jafre 1977 Behavioral despair in rats and mice: Reversal by antidepressants Psychopharmacology 51 291 298
7. M.A. Thomas A.P. Smith 2006 An investigation of the longterm benefits of antidepressant medication in the recovery of patients with chronic fatigue syndrome Hum Psychopharmacol 21 503 509 10.1002/hup.805 1:CAS:528: DC%2BD2sXhvFSmtLw%3D 16981220 (Pubitemid 46062138)
8. S. Fulle P. Mecocci G. Fano 2000 Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome Free Radic Biol Med 29 1252 1259 10.1016/S0891-5849(00)00419-6 1:CAS:528:DC%2BD3cXoslGnsrs%3D 11118815
9. F.U. Fontella I.R. Siqueira A.P. Vasconcellos A.S. Tabajara C.A. Netto C. Dalmaz 2005 Repeated restraint stress induces oxidative damage in rat hippocampus Neurochem Res 30 105 111 10.1007/s11064-004-9691-6 1:CAS:528:DC%2BD2MXotV2gug%3D%3D 15756938 (Pubitemid 40254210)
10. J.M. Silakova J.A. Hewett S.J. Hewett 2004 Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window J Pharmacol Exp Ther 309 1060 1066 10.1124/jpet.103.063867 1:CAS:528:DC%2BD2cXksFCntrk%3D 14769833 (Pubitemid 38669692)
11. A. Dhir S.S.V. Padi P.S. Naidu S.K. Kulkarni 2006 Protective effect of naproxen (nonselective COX-inhibitors) or rofecoxib (selective COX-2 inhibitor) in immobilization stress-induced behavioural and biochemical alterations in mice Eur J Pharmacol 535 192 198 10.1016/j.ejphar.2006.01.064 1:CAS:528: DC%2BD28XjtFGmu7c%3D 16522321
12. L. Minghetti 2004 Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases J Neuropathol Exp Neurol 63 901 910 1:CAS:528:DC%2BD2cXotFajt7k%3D 15453089
13. M. Asanuma I. Miyazaki N. Ogawa 2004 Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases Curr Pharm Des 10 695 700 10.2174/1381612043453072 1:CAS:528:DC%2BD2cXhvFOku7k%3D 14965332 (Pubitemid 38292397)
14. R.I. Galvao J.P. Diogenes G.C. Maia E.A. Filho S.M. Vasconcelos D.B. de Menezes, et al. 2005 Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats Neurochem Res 30 39 46 10.1007/s11064-004-9684-5 1:CAS:528:DC%2BD2MXotV2ntw%3D%3D 15756931 (Pubitemid 40254203)
15. P. Klivenyi M. Kiaei G. Gardian N.Y. Calingasan M.F. Beal 2004 Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis J Neurochem 88 576 582 10.1046/j.1471-4159.2003.02160.x 1:CAS:528:DC%2BD2cXhtVaisb4%3D 14720207 (Pubitemid 38140202)
16. M. Katori M. Majima 2000 Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors Inflamm Res 49 367 392 10.1007/s000110050605 1:CAS:528:DC%2BD3cXntVSgs7k%3D 11028754
17. D.S. Reddy S.K. Kulkarni 1998 Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment Brain Res 799 215 229 10.1016/S0006-8993(98)00419-3 1:CAS:528:DyaK1cXksVyrtbc%3D 9675286 (Pubitemid 28351250)
18. S.K. Kulkarni D.S. Reddy 1996 Animal behavioral models for testing antianxiety agents Method Find Exp Clin Pharmacol 18 219 230 1:CAS:528:DyaK28XjslGntbc%3D
19. J. Ioth T. Nabeshima T. Kameyania 1999 Utility of an elevated plusmaze for dissociation of amnesic and behavioral effects of drugs in mice Eur J Pharmacol 194 71 74 10.1016/0014-2999(91)90125-A
20. E.D. Wills 1966 Mechanism of lipid peroxide formation in animal tissues Biochem J 99 667 676 1:CAS:528:DyaF28XhtVKis7k%3D 5964963
21. G.L. Ellman 1959 Tissue sulfhydryl groups Arch Biochem Biophys 82 70 77 10.1016/0003-9861(59)90090-6 1:CAS:528:DyaG1MXotl2ksA%3D%3D 13650640
22. Luck H. Catalase. Methods of Enzymatic Analysis. New York: Bergmeyer HU (eds) Academic Press 1971: 885-893.
23. L.C. Green D.A. Wagner J. Glagowski 1982 Analysis of nitrate, nitrite and [15N] nitrate in biological fluids Anal Biochem 126 131 138 10.1016/0003-2697(82)90118-X 1:CAS:528:DyaL38XlvFGgtLY%3D 7181105 (Pubitemid 13203451)
24. O.H. Lowry N.J. Rosenberg A.L. Farr R.J. Randall 1951 Protein measurement with the Folin-phenol reagent J Biol Chem 193 265 275 1:CAS:528: DyaG38XhsVyrsw%3D%3D 14907713
25. G. Kaur S.K. Kulkarni 1998 Reversal of forced swimming-induced chronic fatigue in mice by antidepressant and herbal psychotropic drugs Indian Drugs 35 771 777 1:CAS:528:DyaK1MXlvFSmtw%3D%3D
26. L.D. Devanur J.R. Kerr 2006 Chronic fatigue syndrome J Clin Virol 37 139 150 10.1016/j.jcv.2006.08.013 1:CAS:528:DC%2BD28XhtVygt7nF 16978917 (Pubitemid 44548485)
27. A.J. Cleare 2004 The HPA axis and the genesis of chronic fatigue syndrome Trends Endocrinol Metab 15 55 59 10.1016/j.tem.2003.12.002 1:CAS:528: DC%2BD2cXhsV2rs78%3D 15036250 (Pubitemid 38253006)
28. G. Kaur S.K. Kulkarni 2000 Comparative study of antidepressants and herbal psychotropic drugs in a mouse model chronic fatigue J Chronic Fatigue Syndr 6 23 35 10.1300/J092v06n02-04
29. A. Singh P.S. Naidu S. Gupta S.K. Kulkarni 2002 Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome J Med Food 5 211 220 10.1089/109662002763003366 1:CAS:528:DC%2BD3sXhs1yitbk%3D 12639396
30. A. Kumar R. Garg P. Kumar 2008 Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic fatigue syndrome Pharmacol Rep 60 664 672 1:CAS:528:DC%2BD1MXisFCgtLw%3D 19066412
31. C. Schonfeldt-Locuona B.J. Connemann R.C. Wolf M. Braun R.W. Freudenmann 2006 Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression Episode Pharmacopsych 39 152 154 10.1055/s-2006-946706 (Pubitemid 44199184)
32. S. Greenberg M. Frid 2006 Chronic fatigue syndrome-exercise and physical activity Harefuah 145 276 280 16642630
33. G.A. Metz N.M. Jadavji L.K. Smith 2005 Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior Eur J Neurosci 22 1190 1200 10.1111/j.1460-9568.2005.04285.x 16176362 (Pubitemid 41395384)
34. E. Domanski F. Przekop E. Wolinska-Witort K. Mateusiak L. Chomicka S. Garwacki 1986 Differential behavioral and hormonal responses to two different stressors (foot shocking and immobilization) in sheep Exp Clin Pharmacol 88 165 172 1:CAS:528:DyaL2sXhtFOhtL4%3D
35. D.J. Bristow D.S. Holmes 2007 Cortisol levels and anxiety related behaviors in cattle Physiol Behav 90 626 628 10.1016/j.physbeh.2006.11.015 1:CAS:528:DC%2BD2sXisVWhsbw%3D 17196624 (Pubitemid 46329710)
36. A. Dhir S.S.V. Padi P.S. Naidu S.K. Kulkarni 2006 Protective effect of naproxen (nonselective COX-2-inhibitors) or rofecoxib (selective COX-2 inhibitor) in immobilization stress-induced behavioral and biochemical alterations in mice Eur J Pharmacol 535 192 198 10.1016/j.ejphar.2006.01.064 1:CAS:528:DC%2BD28XjtFGmu7c%3D 16522321
37. R. Goyal A. Kumar 2007 Protective effects of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice Pharmacol Rep 59 284 290 1:CAS:528:DC%2BD2sXhtFOltbvL 17652828 (Pubitemid 47299729)
38. N.K. Jain S.K. Kulkarni A. Singh 2001 Lipopolysaccharidemediated immobility in mice: reversal by cyclooxygenase enzyme inhibitor Methods Find Exp Clin Pharmacol 23 441 444 10.1358/mf.2001.23.8.662131 1:CAS:528: DC%2BD38XnsVSnsg%3D%3D 11838318
39. M.B. Mattamml R. Strong V.M. Lakshmi H.D. Chung A.H. Stephenson 1995 Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease J Neurochem 64 1645 1650
40. D.B. Cook P.R. Nagelkirk A. Peckerman A. Poluri J. Mores B.H. Natelson 2005 Exercise and cognitive performance in chronic fatigue syndrome Med Sci Sports Exerc 37 1460 1467 10.1249/01.mss.0000179921.48404.ef 16177595 (Pubitemid 41368487)
41. B. Roozendaal 2000 Glucocorticoids and the regulation of memory consolidation Psychoneuroendocrinol 25 213 238 10.1016/S0306-4530(99)00058-X 1:CAS:528:DC%2BD3cXhtFajsro%3D (Pubitemid 30089730)
42. R. Garcia 2001 Stress hippocampal plasticity and spatial learning Synapse 40 180 183 10.1002/syn.1040 1:CAS:528:DC%2BD3MXjtFKlurw%3D 11304755 (Pubitemid 32322210)
43. B.S. McEwen D. Albeck H. Cameron 1995 Stress and the brain: a paradoxical role for adrenal steroids Vitam Horm 51 371 402 10.1016/S0083-6729(08)61045-6 1:CAS:528:DyaK28Xmt1ahtA%3D%3D 7483328
44. W.E. Kaufmann P.F. Worley J. Pegg M. Bremer P. Isakson 1997 Cyclooxygenase 2 expression during rat neocortical development and in Rett syndrome Brain Dev 19 25 34 10.1016/S0387-7604(96)00047-2 1:STN:280: DyaK2s3isFWitg%3D%3D 9071487 (Pubitemid 27116980)
45. M. Cakala A.R. Malik J.B. Storsznajder 2007 Inhibitor of cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice Pharmacol Rep 59 164 172 1:CAS:528:DC%2BD2sXhtVCqsLjM 17556794
46. V. Luine M. Villegas C. Martinez B.S. McEwen 1994 Repeated stress causes reversible impairments of spatial memory performance Brain Res 639 167 170 10.1016/0006-8993(94)91778-7 1:STN:280:DyaK2c3js1Chuw%3D%3D 8180832 (Pubitemid 24067449)
47. J.L. Madrigal R. Olivenza M.A. Moro I. Lizasoain P. Lorenzo J. Rodrigo, et al. 2001 Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain Neuropsychopharmacology 24 420 429 10.1016/S0893-133X(00)00208-6 1:CAS:528:DC%2BD3MXht12gtbg%3D 11182537 (Pubitemid 32157558)
48. B.S. McEwen 2000 The neurobiology of stress: From serendipity to clinical relevance Brain Res 886 172 189 10.1016/S0006-8993(00)02950-4 1:CAS:528:DC%2BD3cXovFGktb4%3D 11119695
49. L.P. Reagan B.S. McEwen 1997 Controversies surrounding glucocorticoids-mediated cell death in the hippocampus J Chem Neuroanat 13 149 167 10.1016/S0891-0618(97)00031-8 1:CAS:528:DyaK2sXms1Sju7c%3D 9315966 (Pubitemid 27424931)
50. L.J. McIntosh K.E. Hong R.M. Sapolsky 1998 Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies Brain Res 791 209 214 10.1016/S0006-8993(98)00115-2 1:CAS:528:DyaK1cXivVCkt74%3D 9593898 (Pubitemid 28238327)
51. M. Maes 2009 Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms Curr Opin Psychiatry 22 1 75 83 10.1097/YCO.0b013e32831a4728 19127706
52. A. Tomoda T. Joudoi M. Rabab el T. Matsumoto T.H. Park T. Miike 2005 Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls Psychiatry Res 134 101 104 10.1016/j.psychres.2005. 01.002 1:CAS:528:DC%2BD2MXivFSjsLs%3D 15808295 (Pubitemid 40460978)
53. L. Lorusso S.V. Mikhaylova E. Capelli D. Ferrari G.K. Ngonga G. Ricevuti 2009 Immunological aspects of chronic fatigue syndrome Autoimmun Rev 8 287 291 10.1016/j.autrev.2008.08.003 1:CAS:528:DC%2BD1MXmtVyqsrw%3D 18801465
54. R.S. Richard L. Wang H. Jelinek 2007 Erythrocyte oxidative damage in chronic fatigue syndrome Arch Med Res 38 94 98 10.1016/j.arcmed.2006.06.008 (Pubitemid 44894610)
55. M.E. Ozcan M. Gulec E. Ozerol R. Polat O. Akyol 2004 Antioxidant enzyme activities and oxidative stress in affective disorders Int Clin Psychopharmacol 19 89 95 10.1097/00004850-200403000-00006 15076017 (Pubitemid 38316767)
56. 2+-dependent caspase-2 activation induced by oxidative stress leads to SH-SY5Y human neuroblastoma cell apoptosis J Neurosci Res 68 454 462 10.1002/jnr.10199 1:CAS:528:DC%2BD38XjsFGqs78%3D 11992472 (Pubitemid 34461576)
57. J.M. Braughler E.D. Hall 1989 Central nervous system trauma and stroke. Biochemical considerations for free radical dormation and lipid peroxidation Free Rad Biol Med 6 289 301 10.1016/0891-5849(89)90056-7 1:STN:280: DyaL1Mzgs1ymtA%3D%3D 2663662 (Pubitemid 19076495)
58. Y. Hu A. Cardounel E. Gursoy P. Anderson M. Kalimi 2000 Anti-stress effects of dehydroepiandrosterone. Protection of rats against repeated immobilization stressinduced weight loss, glucocorticoid receptor production, and lipid peroxidation Biochem Pharmacol 59 753 762 10.1016/S0006-2952(99)00385- 8 1:CAS:528:DC%2BD3cXpsVWmtg%3D%3D 10718333 (Pubitemid 30081698)
59. R. Olivenza M.A. Moro I. Lizasoain P. Lorenzo A.P. Fernández J. Rodrigo, et al. 2000 Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex J Neurochem 74 785 791 10.1046/j.1471-4159. 2000.740785.x 1:CAS:528:DC%2BD3cXntFyitQ%3D%3D 10646531 (Pubitemid 30053752)
60. K. Matsumoto K. Yobimoto N.T.T. Huong M. Abdel-Fattah T.V. Hein H. Watanable 1999 Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice Brain Res 839 74 84 10.1016/S0006-8993(99)01715-1 1:CAS:528:DyaK1MXlt1ShsLo%3D 10482801 (Pubitemid 29389795)
61. M. Maes I. Mihylova M. Kubera E. Bosmans 2007 Not in the mind but in the cell: increased production of cyclooxygenase-2 and inducible NO synthase in chronic fatigue syndrome Neuro Endocrinol Lett 28 463 469 1:CAS:528: DC%2BD2sXht12rt7vN 17693978
62. R.L. Torres L.S. Torresi G.D. Gamaro F.U. Fontella P.P. Silveira J.S.R. Moreira, et al. 2004 Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and subchronic stress Braz J Med Biol Res 37 185 192 10.1590/S0100-879X2004000200004 1:CAS:528:DC%2BD2cXisFCqtbw%3D 14762572
63. M. Bilici H. Efe M.A. Koroglu H.A. Uydu M. Bekaroglu O. Deger 2001 Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments J Affect Disord 64 43 51 10.1016/S0165-0327(00)00199-3 1:CAS:528:DC%2BD3MXkvVerur8%3D 11292519 (Pubitemid 32268670)
64. R.M. Sapolsky 2000 The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death Biol Psychiatry 48 755 765 10.1016/S0006-3223(00)00971-9 1:STN:280:DC%2BD3crht1Siuw%3D%3D 11063972 (Pubitemid 30813461)